Conclusion: PA promotes EMT of ARPE-19 cells via regulating the miR-143-5p/JDP2 axis, and these findings provide significant insights into the potential targeting of this axis to treat proliferative vitreoretinopathy. The gene discussed is JDP2; the disease is CAPN5-related vitreoretinopathy.